title: Sweet's syndrome following abacavir therapy.
authors.forename: P
authors.initials: P
authors.lastname: Del Giudice
authors.forename: F
authors.initials: F
authors.lastname: Vandenbos
authors.forename: C
authors.initials: C
authors.lastname: Perrin
authors.forename: E
authors.initials: E
authors.lastname: Bernard
authors.forename: L
authors.initials: L
authors.lastname: Marq
authors.forename: P
authors.initials: P
authors.lastname: Dellamonica
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D019888:Nelfinavir / Q000008:administration & dosage / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016463:Sweet Syndrome / Q000139:chemically induced*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D019259:Lamivudine; D019888:Nelfinavir; D018894:Reverse Transcriptase Inhibitors; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000099227:Abacavir